[1]
VieiraM.S., VieiraA.L.S., RezendeA.C.A., PereiraJ.C.R., CostaM.I.A., NogueiraA.A. de A., SantosG.P., RibeiroF.F. and MaiaL.F. 2021. The use of renin angiotensin aldosterone system inhibitors in hypertensive patients with COVID-19. Electronic Journal Collection Health. 13, 10 (Oct. 2021), e8779. DOI:https://doi.org/10.25248/reas.e8779.2021.